{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:12Z","timestamp":1790802672713,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypercalcemia and hyperparathyroidism in patients receiving maintenance hemodialysis (MHD) can cause the progression of cardiovascular diseases (CVD) and mineral bone disorders (MBD). The KDIGO recommends the dialysates with a calcium (Ca) concentration of 1.25\u20131.5\u2009mmol\/L for MHD treatments, but the optimal concentration remains controversial. Here, we conducted a systematic review and a meta-analysis of seven randomized controlled trials examining a total of 622 patients to investigate the optimal concentration for MHD for 6 months or longer. The dialysates with a low Ca concentration (1.125 or 1.25\u2009mmol\/L) significantly lowered the serum Ca and raised the intact parathyroid hormone levels by 0.52\u2009mg\/dL (95% confidence interval, 0.20\u20130.85) and 39.59\u2009pg\/mL (14.80\u201364.38), respectively, compared with a high Ca concentration (1.50 or 1.75\u2009mmol\/L). Three studies showed that a low concentration was preferred for lowering arterial calcifications or atherosclerosis in different arteries, but one study showed that coronary arterial calcifications increased with a low concentration. Two studies showed contradictory outcomes in terms of MBD. Our meta-analysis showed that a dialysate with a low Ca concentration lowered the serum Ca levels in patients receiving long-term MHD, but further studies are needed to determine the optimal Ca concentration in terms of CVD and MBD.<\/jats:p>","DOI":"10.1038\/s41598-018-23658-y","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T02:00:05Z","timestamp":1522288805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-term effects of low calcium dialysates on the serum calcium levels during maintenance hemodialysis treatments: A systematic review and meta-analysis"],"prefix":"10.1038","volume":"8","author":[{"given":"Masahiro","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-0150","authenticated-orcid":false,"given":"Taro","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matsuhiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Takato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"23658_CR1","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1681\/ASN.2005060662","volume":"16","author":"CR Nolan","year":"2005","unstructured":"Nolan, C. R. Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol. 16, S120\u2013127 (2005).","journal-title":"J Am Soc Nephrol."},{"key":"23658_CR2","first-page":"59","volume":"35","author":"PB McCarley","year":"2008","unstructured":"McCarley, P. B. & Arjomand, M. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. Nephrol Nurs J. 35, 59\u201364 (2008).","journal-title":"Nephrol Nurs J."},{"key":"23658_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrneph.2014.8","volume":"10","author":"DJ de Jager","year":"2014","unstructured":"de Jager, D. J., Vervloet, M. G. & Dekker, F. W. Noncardiovascular mortality in CKD: an epidemiological perspective. Nature Reviews Nephrology. 10, 208\u2013214 (2014).","journal-title":"Nature Reviews Nephrology."},{"key":"23658_CR4","first-page":"S50","volume":"38","author":"A Fournier","year":"1992","unstructured":"Fournier, A. et al. Use of alkaline calcium salts as phosphate binder in uremic patients. Kidney Int. 38, S50\u201361 (1992).","journal-title":"Kidney Int."},{"key":"23658_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.semnephrol.2009.01.004","volume":"29","author":"TV Patel","year":"2009","unstructured":"Patel, T. V. & Singh, A. K. Role of vitamin D in chronic kidney disease. Semin Nephrol. 29, 113\u2013121 (2009).","journal-title":"Semin Nephrol."},{"key":"23658_CR6","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1517\/14656566.2015.1092521","volume":"16","author":"G Spasovski","year":"2015","unstructured":"Spasovski, G. Advances in pharmacotherapy for hyperphosphatemia in renal disease. Expert Opin Pharmacother. 16, 2589\u20132599 (2015).","journal-title":"Expert Opin Pharmacother."},{"key":"23658_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1525-139X.2005.18318.x","volume":"18","author":"I Shahapuni","year":"2005","unstructured":"Shahapuni, I. et al. How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients? Semin Dial. 18, 226\u2013238 (2005).","journal-title":"Semin Dial."},{"key":"23658_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ki.2010.157","volume":"78","author":"FA Gotch","year":"2010","unstructured":"Gotch, F. A., Kotanko, P., Thijssen, S. & Levin, N. W. The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients. Kidney Int. 78, 343\u2013350 (2010).","journal-title":"Kidney Int."},{"key":"23658_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler, M. et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney Int. 92, 26\u201336 (2017).","journal-title":"Kidney Int."},{"key":"23658_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijcard.2017.05.008","volume":"243","author":"SJ Kim","year":"2017","unstructured":"Kim, S. J., Lee, Y. K., Oh, J., Cho, A. & Noh, J. W. Effects of low calcium dialysate on the progression of coronary artery calcification in hemodialysis patients: An open-label 12-month randomized clinical trial. Int J Cardiol. 243, 431\u2013436 (2017).","journal-title":"Int J Cardiol."},{"key":"23658_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000450747","volume":"42","author":"Z He","year":"2016","unstructured":"He, Z. et al. Effects of Lowering Dialysate Calcium Concentration on Carotid Intima-Media Thickness and Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis: A Prospective Study. Blood Purif. 42, 337\u2013346 (2016).","journal-title":"Blood Purif."},{"key":"23658_CR12","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1681\/ASN.2015030268","volume":"27","author":"E Ok","year":"2016","unstructured":"Ok, E. et al. Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol. 27, 2475\u20132486 (2016).","journal-title":"J Am Soc Nephrol."},{"key":"23658_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000443470","volume":"42","author":"JR Lu","year":"2016","unstructured":"Lu, J. R. et al. The Study of Low Calcium Dialysate on Elderly Hemodialysis Patients with Secondary Hypoparathyroidism. Blood Purif. 42, 3\u20138 (2016).","journal-title":"Blood Purif."},{"key":"23658_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.bone.2007.06.014","volume":"41","author":"G Spasovski","year":"2007","unstructured":"Spasovski, G. et al. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium. Bone. 41, 698\u2013703 (2007).","journal-title":"Bone."},{"key":"23658_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1359\/jbmr.2000.15.5.927","volume":"15","author":"R Holgado","year":"2000","unstructured":"Holgado, R. et al. Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis. J Bone Miner Res. 15, 927\u2013935 (2000).","journal-title":"J Bone Miner Res."},{"key":"23658_CR16","first-page":"254","volume":"20","author":"MC S\u00e1nchez Perales","year":"2000","unstructured":"S\u00e1nchez Perales, M. C. et al. Hemodialysis with 2.5 mEq\/L of calcium in relative hypoparathyroidism: long-term effects on bone mass. Nefrologia. 20, 254\u2013261 (2000).","journal-title":"Nefrologia."},{"key":"23658_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher, D. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097 (2009).","journal-title":"PLoS Med."},{"key":"23658_CR18","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins, J. P. et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 343, d5928 (2011).","journal-title":"BMJ."},{"key":"23658_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50, 1088\u20131101 (1994).","journal-title":"Biometrics."},{"key":"23658_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315, 629\u2013634 (1997).","journal-title":"BMJ."},{"key":"23658_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"Tentori, F. et al. Recent Changes in Therapeutic Approaches and Association with Outcomes among Patients with Secondary Hyperparathyroidism on Chronic Hemodialysis: The DOPPS Study. Clin J Am Soc Nephrol. 10, 98\u2013109 (2015).","journal-title":"Clin J Am Soc Nephrol."},{"key":"23658_CR22","first-page":"2031","volume":"8","author":"XY Cao","year":"2015","unstructured":"Cao, X. Y. et al. Long term effects on mineral and bone metabolism by low versus standard calcium dialysate in peritoneal dialysis: a meta-analysis. Int J Clin Exp Med. 8, 2031\u20132037 (2015).","journal-title":"Int J Clin Exp Med."},{"key":"23658_CR23","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1093\/ndt\/gfr138","volume":"26","author":"A LeBoeuf","year":"2011","unstructured":"LeBoeuf, A. et al. Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant. 26, 3695\u20133701 (2011).","journal-title":"Nephrol Dial Transplant."},{"key":"23658_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/sj.ki.5001666","volume":"70","author":"A Haris","year":"2006","unstructured":"Haris, A., Sherrard, D. J. & Hercz, G. Reversal of adynamic bone disease by lowering of dialysate calcium. Kidney Int. 70, 931\u2013937 (2006).","journal-title":"Kidney Int."},{"key":"23658_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.1994.342","volume":"46","author":"P Kurz","year":"1994","unstructured":"Kurz, P. et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 46, 855\u2013861 (1994).","journal-title":"Kidney Int."},{"key":"23658_CR26","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"GM London","year":"2004","unstructured":"London, G. M. et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 15, 1943\u20131951 (2004).","journal-title":"J Am Soc Nephrol."},{"key":"23658_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.ajkd.2013.02.357","volume":"62","author":"DL Zimmerman","year":"2013","unstructured":"Zimmerman, D. L. et al. Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis: a systematic review and meta-analysis for a Canadian Society of Nephrology clinical practice guideline. Am J Kidney Dis. 62, 97\u2013111 (2013).","journal-title":"Am J Kidney Dis."},{"key":"23658_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1681\/ASN.2011070688","volume":"23","author":"JT Daugirdas","year":"2012","unstructured":"Daugirdas, J. T. et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol. 23, 727\u2013738 (2012).","journal-title":"J Am Soc Nephrol."},{"key":"23658_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.15386\/cjmed-515","volume":"89","author":"D Moldovan","year":"2016","unstructured":"Moldovan, D. et al. Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis. Clujul Med. 89, 94\u2013103 (2016).","journal-title":"Clujul Med."},{"key":"23658_CR30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul, M. et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 70, 1358\u20131366 (2006).","journal-title":"Kidney Int."},{"key":"23658_CR31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto, F. C. et al. K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int. 73, 771\u2013777 (2008).","journal-title":"Kidney Int."},{"key":"23658_CR32","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"EVOLVE","year":"2012","unstructured":"EVOLVE. Trial Investigators. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 367, 2482\u20132494 (2012).","journal-title":"N Engl J Med."},{"key":"23658_CR33","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 339, b2700 (2009).","journal-title":"BMJ."},{"key":"23658_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ. 327, 557\u2013560 (2003).","journal-title":"BMJ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23658-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:56:01Z","timestamp":1671594961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23658-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23658"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23658-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5310"}}